Prevention of Deep Vein Thrombosis by Panax Notoginseng Saponins Combined with Low-Molecular-Weight Heparin in Surgical Patients

被引：0
|
作者：
Chun-mei Wang
Xiang-feng Guo
Li-min Liu
Ying Huang
Liang Meng
Li-po Song
Ying-feng Wu
Ya-chan Ning
Kathleen H. Reilly
Hai-bo Wang
机构：
[1] Capital Medical University,Department of Vascular Surgery, Xuanwu Hospital
[2] Children’s Hospital Capital Institute of Pediatrics,Department of Orthopaedics, Xuanwu Hospital
[3] Capital Medical University,Peking University Clinical Research Institute
[4] Centers for Disease Control and Prevention,undefined
[5] Peking University First Hospital,undefined
来源：
Chinese Journal of Integrative Medicine | 2022年 / 28卷
关键词：
panax notoginseng saponins; deep vein thrombosis; low-molecular-weight heparin; thromboelastography; risk factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：771 / 778
页数：7
相关论文
共 50 条
  • [1] Prevention of Deep Vein Thrombosis by Panax Notoginseng Saponins Combined with Low-Molecular-Weight Heparin in Surgical Patients
    Wang Chun-mei
    Guo Xiang-feng
    Liu Li-min
    Huang Ying
    Meng Liang
    Song Li-po
    Wu Ying-feng
    Ning Ye-chan
    Reilly, Kathleen H.
    Wang Hai-bo
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2022, 28 (09) : 771 - 778
  • [2] Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients
    Levine, M
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2003, 29 : 9 - 11
  • [3] Low-Molecular-Weight Heparin in the Initial Treatment of Proximal Deep Vein Thrombosis
    Karen Aileen Valentine
    Graham Frederick Pineo
    Russell Douglas Hull
    Journal of Thrombosis and Thrombolysis, 1997, 4 (3-4) : 345 - 347
  • [4] RANDOMIZED CONTROLLED-STUDY OF HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN FOR PREVENTION OF DEEP-VEIN THROMBOSIS IN MEDICAL PATIENTS
    HARENBERG, J
    KALLENBACH, B
    MARTIN, U
    DEMPFLE, CE
    ZIMMERMANN, R
    KUBLER, W
    HEENE, DL
    THROMBOSIS RESEARCH, 1990, 59 (03) : 639 - 650
  • [5] PREVENTION OF DEEP-VEIN THROMBOSIS BY LOW-MOLECULAR-WEIGHT HEPARIN AND DIHYDROERGOTAMINE IN PATIENTS UNDERGOING TOTAL HIP-REPLACEMENT
    FREICK, H
    HAAS, S
    THROMBOSIS RESEARCH, 1991, 63 (01) : 133 - 143
  • [6] LOW-MOLECULAR-WEIGHT HEPARIN WITHOUT ORAL ANTICOAGULANTS FOR THE TREATMENT OF DEEP VEIN THROMBOSIS
    Alonso Martinez, J. L.
    Abinzano Guillen, M. L.
    Urbieta Echezarreta, M. A.
    Annicherico Sanchez, F. J.
    Fernandez Ladron, V.
    Garcia Sanchotena, J. L.
    ANALES DE MEDICINA INTERNA, 2008, 25 (01) : 4 - 8
  • [7] Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis
    Harenberg, J
    Stehle, G
    Blauth, M
    Huck, K
    Mall, K
    Heene, DL
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (01): : 83 - 90
  • [8] The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: Outcome of therapy and health economy aspects - Low-molecular-weight heparin versus unfractionated heparin
    Hull, RD
    Pineo, GF
    Raskob, GE
    HAEMOSTASIS, 1998, 28 : 8 - 16
  • [9] The Effect of Intermittent Pneumatic Compression Device Combined with Low-Molecular-Weight Heparin on the Prevention of Deep Vein Thrombosis in Elderly Patients after Femoral Neck Fracture Surgery
    Li, Chen
    Xie, Xi
    Zheng, Hao-tian
    Gao, Xi
    Li, Cheng-yuan
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2024, 85 (10)
  • [10] Low molecular weight heparin for deep vein thrombosis in glioma patients
    Schmidt, F
    Faul, C
    Dichgans, J
    Weller, M
    JOURNAL OF NEUROLOGY, 2002, 249 (10) : 1409 - 1412
12345